Home › Liposarcoma › Michigan
Liposarcoma clinical trials in Michigan
5 studies for Liposarcoma are looking for participants at sites in Michigan.
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Hospital of Michigan/Wayne State University, Detroit
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Nov 12, 2026 · NCT06541262Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
- University of Michigan Rogel Cancer Center, Ann Arbor
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Macomb Hospital-Clinton Township, Clinton Township
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06422806Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- START Midwest, Grand Rapids
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT04557449STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- START Midwest, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06975293Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- University of Michigan Comprehensive Cancer Center, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT04031677From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.